2,969
Views
2
CrossRef citations to date
0
Altmetric
Review Article

Kisspeptin as a predictor of miscarriage: a systematic review

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Article: 2197097 | Received 21 May 2022, Accepted 26 Mar 2023, Published online: 04 Apr 2023

References

  • Kotani M, Detheux M, Vandenbogaerde A, et al. The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. J Biol Chem. 2001;276(37):34631–34636.
  • Padda J, Khalid K, Moosa A, et al. Role of kisspeptin on hypothalamic-pituitary-gonadal pathology and its effect on reproduction. Cureus. 2021;13(8):e17600.
  • Hu KL, Chang HM, Zhao HC, et al. Potential roles for the kisspeptin/kisspeptin receptor system in implantation and placentation. Hum Reprod Update. 2019;25(3):326–343.
  • D'Occhio MJ, Campanile G, Baruselli PS. Peripheral action of kisspeptin at reproductive tissues-role in ovarian function and embryo implantation and relevance to assisted reproductive technology in livestock: a review. Biol Reprod. 2020;103(6):1157–1170.
  • Zeydabadi Nejad S, Ramezani Tehrani F, Zadeh-Vakili A. The role of kisspeptin in female reproduction. Int J Endocrinol Metab. 2017;15(3):e44337.
  • Harter CJL, Kavanagh GS, Smith JT. The role of kisspeptin neurons in reproduction and metabolism. J Endocrinol. 2018;238(3):R173–R183.
  • Pinilla L, Aguilar E, Dieguez C, et al. Kisspeptins and reproduction: physiological roles and regulatory mechanisms. Physiol Rev. 2012;92(3):1235–1316.
  • Gorbunova OL, Shirshev SV. Role of kisspeptin in regulation of reproductive and immune reactions. Biochemistry Moscow. 2020;85(8):839–853.
  • Gorkem U, Kan O, Bostanci MO, et al. Kisspeptin and hematologic parameters as predictive biomarkers for first-trimester abortions. Medeni Med J. 2021;36(2):98–105.
  • Abbara A, Al-Memar M, Phylactou M, et al. Performance of plasma kisspeptin as a biomarker for miscarriage improves with gestational age during the first trimester. Fertil Steril. 2021;116(3):809–819.
  • Arslan E, Gorkem U, Togrul C. Is there an association between kisspeptin levels and gestational diabetes mellitus? Gynecol Obstet Reprod Med. 2020;26(3):179–183.
  • Ćetković A, Miljic D, Ljubić A, et al. Plasma kisspeptin levels in pregnancies with diabetes and hypertensive disease as a potential marker of placental dysfunction and adverse perinatal outcome. Endocr Res. 2012;37(2):78–88.
  • Abbara A, Al-Memar M, Phylactou M, et al. Changes in circulating kisspeptin levels during each trimester in women with antenatal complications. J Clin Endocrinol Metab. 2022;107(1):e71–e83.
  • Jayasena CN, Abbara A, Izzi-Engbeaya C, et al. Reduced levels of plasma kisspeptin during the antenatal booking visit are associated with increased risk of miscarriage. J Clin Endocrinol Metab. 2014;99(12):E2652–E2660.
  • Sullivan-Pyke C, Haisenleder DJ, Senapati S, et al. Kisspeptin as a new serum biomarker to discriminate miscarriage from viable intrauterine pregnancy. Fertil Steril. 2018;109(1):137–141.e2.
  • Savaris RF. Kisspeptin as a biomarker for miscarriage: let’s wait!. Fertil Steril. 2018;109(1):67.
  • Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
  • Reitsma JB, Moons KG, Bossuyt PM, et al. Systematic reviews of studies quantifying the accuracy of diagnostic tests and markers. Clin Chem. 2012;58(11):1534–1545.
  • Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529–536.
  • Mumtaz A, Khalid A, Jamil Z, et al. Kisspeptin: a potential factor for unexplained infertility and impaired embryo implantation. Int J Fertil Steril. 2017;11(2):99–104.
  • Yu H, Liu J, Guo H, et al. Prognostic value of repeated serum kisspeptin measurements in early first trimester pregnancy: a preliminary study. Reprod Biomed Online. 2019;38(3):465–471.
  • Memtsa M, Jurkovic D, Jauniaux E, Royal college of obstetricians and gynaecologists. Diagnostic biomarkers for predicting adverse early pregnancy outcomes: scientific impact paper no. 58. BJOG: int J Obstet Gy. 2019;126(3):e107–e113.
  • Dimitriadis E, Menkhorst E, Saito S, et al. Recurrent pregnancy loss. Nat Rev Dis Primers. 2020;6(1):98.
  • Hu KL, Zhang Y, Yang Z, et al. Predictive value of serum kisspeptin concentration at 14 and 21 days after frozen-thawed embryo transfer. Reprod Biomed Online. 2019; 39(1):161–167.
  • Horikoshi Y, Matsumoto H, Takatsu Y, et al. Dramatic elevation of plasma metastin concentrations in human pregnancy: metastin as a novel placenta-derived hormone in humans. J Clin Endocrinol Metab. 2003;88(2):914–919.
  • Yu Z, Kastenmüller G, He Y, et al. Differences between human plasma and serum metabolite profiles. PLOS One. 2011;6(7):e21230.
  • Ramachandran R, Patterson M, Murphy KG, et al. Preanalytical factors affecting RIA measurement of plasma kisspeptin. Clin Chem. 2008;54(3):615–617.
  • Hassan A, Kotb M, AwadAllah A, et al. Follicular output rate can predict clinical pregnancy in women with unexplained infertility undergoing IVF/ICSI: a prospective cohort study. Reprod Biomed Online. 2017;34(6):598–604.
  • Mellor AL, Munn DH. Tryptophan catabolism prevents maternal T cells from activating lethal anti-fetal immune responses. J Reprod Immunol. 2001;52(1-2):5–13.
  • Liu YS, Wu L, Tong XH, et al. Study on the relationship between Th17 cells and unexplained recurrent spontaneous abortion. Am J Reprod Immunol. 2011;65(5):503–511.